GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2026 8:03:43 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $14,826,000 | EPS -$0.14 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2026 7:57:39 AM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $14,826,000 | EPS -$0.14 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2026 7:56:21 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $15,759,000 | EPS -$0.08 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2026 7:51:32 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $15,759,000 | EPS -$0.08 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/31/2026 8:04:26 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $19,532,000 | EPS -$0.48 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/31/2026 7:56:26 AM | View | Financials | Earnings | SEC | Y 2025 | Assets $19,532,000 | EPS -$0.08 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/14/2025 8:03:21 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $12,865,000 | EPS -$0.13 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/14/2025 7:56:45 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $12,865,000 | EPS -$0.13 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 10/22/2025 8:02:44 AM | View | Proxy | SEC | Y 2024 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2025 8:03:22 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $15,602,000 | EPS -$0.12 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2025 7:56:43 AM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $15,602,000 | EPS -$0.12 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2025 8:06:02 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $9,528,000 | EPS -$0.15 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2025 7:56:25 AM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $9,528,000 | EPS -$0.15 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/31/2025 8:04:05 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $17,495,000 | EPS -$0.76 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/31/2025 7:56:04 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $17,495,000 | EPS -$0.19 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 12/3/2024 8:04:25 AM | View | Proxy | SEC | Y 2023 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 11/14/2024 8:01:37 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $28,972,000 | EPS -$0.18 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/14/2024 7:56:45 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $28,972,000 | EPS -$0.18 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/13/2024 8:07:58 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $27,655,000 | EPS -$0.20 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/13/2024 7:56:37 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $27,655,000 | EPS -$0.20 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2024 8:05:49 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $25,890,000 | EPS -$0.19 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2024 7:56:31 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $25,890,000 | EPS -$0.19 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/29/2024 8:05:48 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $28,200,000 | EPS -$0.74 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/29/2024 7:56:38 AM | View | Financials | Earnings | SEC | Y 2023 | Assets $28,200,000 | EPS -$0.16 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/13/2023 9:22:54 AM | View | Correction | SEC | 3Q 2023 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 11/13/2023 8:05:05 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $22,163,000 | EPS -$0.24 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/13/2023 7:58:08 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $22,163,000 | EPS -$0.24 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 10/6/2023 8:04:08 AM | View | Proxy | SEC | Y 2022 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2023 8:05:51 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $20,081,000 | EPS -$0.15 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2023 7:56:12 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $20,081,000 | EPS -$0.15 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2023 8:01:16 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $20,225,000 | EPS -$0.19 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2023 7:56:40 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $20,225,000 | EPS -$0.19 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/30/2023 8:08:42 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $21,285,000 | EPS -$0.65 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/30/2023 7:55:39 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $21,285,000 | EPS -$0.18 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/14/2022 8:07:55 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $17,914,000 | EPS -$0.14 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/14/2022 7:56:59 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $17,914,000 | EPS -$0.14 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 10/17/2022 8:02:08 AM | View | Proxy | SEC | Y 2021 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 8/15/2022 8:09:39 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $25,886,000 | EPS -$0.16 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/15/2022 7:57:56 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $25,886,000 | EPS -$0.16 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/16/2022 8:07:08 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $33,615,000 | EPS -$0.17 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/16/2022 7:58:25 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $33,615,000 | EPS -$0.17 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/31/2022 8:08:52 AM | View | Financials | Earnings | SEC | Y 2021 | Assets $41,827,000 | EPS -$0.12 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/31/2022 7:57:44 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $41,827,000 | EPS -$0.52 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/15/2021 8:05:14 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $38,038,000 | EPS -$0.14 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/15/2021 7:56:21 AM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $38,038,000 | EPS -$0.14 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 10/12/2021 8:02:06 AM | View | Proxy | SEC | Y 2020 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 8/16/2021 9:03:15 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $33,405,000 | EPS -$0.15 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/16/2021 9:01:51 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $33,405,000 | EPS -$0.15 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/17/2021 8:02:39 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $22,897,000 | EPS -$0.11 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/17/2021 7:57:18 AM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $22,897,000 | EPS -$0.11 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/31/2021 8:03:08 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $29,600,000 | EPS -$0.41 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/31/2021 7:54:26 AM | View | Financials | Earnings | SEC | Y 2020 | Assets $29,600,000 | EPS -$0.13 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/9/2020 7:53:39 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $34,049,000 | EPS -$0.10 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/9/2020 7:48:21 AM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $34,049,000 | EPS -$0.10 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 10/19/2020 8:01:58 AM | View | Proxy | SEC | Y 2019 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 8/10/2020 8:05:04 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $41,317,000 | EPS -$0.11 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/10/2020 7:57:09 AM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $41,317,000 | EPS -$0.11 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/11/2020 7:49:50 AM | View | Financials | Earnings | SEC | 1Q 2020 | Assets $44,111,000 | EPS -$0.06 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/11/2020 6:45:32 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $44,111,000 | EPS -$0.06 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/16/2020 8:03:40 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $48,467,000 | EPS -$0.39 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/16/2020 7:58:15 AM | View | Financials | Earnings | SEC | Y 2019 | Assets $48,467,000 | EPS -$0.12 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/12/2019 8:14:05 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $50,760,000 | EPS -$0.05 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/12/2019 7:55:34 AM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $50,760,000 | EPS -$0.05 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 10/17/2019 8:02:51 AM | View | Proxy | SEC | Y 2018 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 8/9/2019 8:03:36 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $53,012,000 | EPS -$0.06 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/9/2019 8:02:06 AM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $53,012,000 | EPS -$0.06 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/10/2019 8:10:54 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $7,830,000 | EPS -$0.20 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/6/2019 8:24:30 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $9,006,000 | EPS -$0.38 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/6/2019 7:56:27 AM | View | Financials | Earnings | SEC | Y 2018 | Assets $9,006,000 | EPS -$0.68 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/13/2018 8:08:30 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $10,616,000 | EPS $0.07 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/13/2018 7:57:15 AM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $10,616,000 | EPS $0.07 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2018 7:57:06 AM | View | Financials | Earnings | SEC | 2Q 2018 | Assets $11,210,000 | EPS $0.11 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2018 7:56:02 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $11,210,000 | EPS $0.11 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/11/2018 4:24:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $4,931,000 | EPS $0.12 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/11/2018 4:15:29 PM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $4,931,000 | EPS $0.12 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 4/11/2018 4:03:42 PM | View | Proxy | SEC | Y 2017 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 3/29/2018 8:14:32 AM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $4,161,000 | EPS -$0.49 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/29/2018 8:06:06 AM | View | Financials | Earnings | SEC | Y 2017 | Assets $4,161,000 | EPS -$0.07 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/7/2017 4:31:04 PM | View | Proxy | SEC | Y 2016 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 11/7/2017 8:14:34 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $6,000 | Assets $7,011,000 | EPS -$0.13 | |
| GALECTIN THERAPEUTICS INC (GALT) | 11/7/2017 8:05:02 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $6,000 | Assets $7,011,000 | EPS -$0.13 | Export Earnings Model | |
| GALECTIN THERAPEUTICS INC (GALT) | 8/18/2017 8:28:35 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $6,000 | Assets $9,329,000 | EPS -$0.14 | Export Earnings Model | |
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2017 8:06:49 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $6,000 | Assets $9,329,000 | EPS -$0.14 | |
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2017 8:05:35 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $6,000 | Assets $9,329,000 | EPS -$0.14 | Export Earnings Model | |
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2017 8:22:26 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $9,000 | Assets $13,997,000 | EPS -$0.15 | |
| GALECTIN THERAPEUTICS INC (GALT) | 5/15/2017 8:21:56 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $9,000 | Assets $13,997,000 | EPS -$0.15 | Export Earnings Model | |
| GALECTIN THERAPEUTICS INC (GALT) | 3/28/2017 8:21:02 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $45,000 | Assets $15,795,000 | EPS -$0.16 | Export Earnings Model | |
| GALECTIN THERAPEUTICS INC (GALT) | 3/28/2017 8:17:25 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $45,000 | Assets $15,795,000 | EPS -$0.76 | |
| GALECTIN THERAPEUTICS INC (GALT) | 11/10/2016 7:01:33 AM | View | Proxy | SEC | Y 2015 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 11/8/2016 7:55:32 AM | View | Financials | Earnings | SEC | 3Q 2016 | Assets $16,115,000 | EPS -$0.16 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/8/2016 7:49:39 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $16,115,000 | EPS -$0.16 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/9/2016 7:50:32 AM | View | Financials | Earnings | SEC | 2Q 2016 | Assets $18,247,000 | EPS -$0.20 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/9/2016 7:41:46 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $18,247,000 | EPS -$0.20 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/10/2016 7:52:40 AM | View | Financials | Earnings | SEC | 1Q 2016 | Assets $22,788,000 | EPS -$0.24 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/10/2016 7:49:33 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $22,788,000 | EPS -$0.24 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/15/2016 7:36:34 AM | View | Financials | Earnings | SEC | Y 2015 | Assets $26,408,000 | EPS -$0.19 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/15/2016 7:34:36 AM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $26,408,000 | EPS -$0.88 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/9/2015 8:00:57 AM | View | Financials | Earnings | SEC | 3Q 2015 | Assets $21,512,000 | EPS -$0.26 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/9/2015 7:51:31 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $21,512,000 | EPS -$0.26 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/10/2015 7:51:00 AM | View | Financials | Earnings | SEC | 2Q 2015 | Assets $26,679,000 | EPS -$0.21 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/10/2015 7:46:53 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $26,679,000 | EPS -$0.21 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/11/2015 7:46:06 AM | View | Financials | Earnings | SEC | 1Q 2015 | Assets $29,974,000 | EPS -$0.22 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/11/2015 7:41:23 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $29,974,000 | EPS -$0.22 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 4/8/2015 4:30:36 PM | View | Proxy | SEC | Y 2014 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 3/18/2015 4:05:36 PM | View | Financials | Earnings | SEC | Y 2014 | Assets $29,677,000 | EPS -$0.17 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/18/2015 4:03:08 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Assets $29,677,000 | EPS -$0.78 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/10/2014 8:02:59 AM | View | Financials | Earnings | SEC | 3Q 2014 | Assets $31,319,000 | EPS -$0.17 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/10/2014 8:01:54 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Assets $31,319,000 | EPS -$0.17 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/7/2014 5:20:34 PM | View | Financials | Earnings | SEC | 2Q 2014 | Assets $34,594,000 | EPS -$0.17 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/7/2014 5:15:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Assets $34,594,000 | EPS -$0.17 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/13/2014 5:13:23 PM | View | Financials | Earnings | SEC | 1Q 2014 | Assets $36,899,000 | EPS -$0.27 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/13/2014 4:30:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $36,899,000 | EPS -$0.27 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/21/2014 5:17:37 PM | View | Proxy | SEC | Y 2013 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 3/21/2014 5:04:23 PM | View | Financials | Earnings | SEC | Y 2013 | Assets $10,713,000 | EPS -$0.14 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/21/2014 5:02:38 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Assets $10,713,000 | EPS -$1.30 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/12/2013 8:45:54 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Assets $9,777,000 | EPS -$0.22 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/12/2013 8:30:36 AM | View | Financials | Earnings | SEC | 3Q 2013 | Assets $9,777,000 | EPS -$0.22 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2013 5:29:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Assets $5,225,000 | EPS -$0.72 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/14/2013 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2013 | Assets $5,225,000 | EPS -$0.72 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/10/2013 11:58:13 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Assets $7,196,000 | EPS -$0.22 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/10/2013 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2013 | Assets $7,196,000 | EPS -$0.22 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 4/12/2013 12:27:41 PM | View | Proxy | SEC | Y 2012 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 4/1/2013 12:00:00 AM | View | Financials | Earnings | SEC | Y 2012 | Assets $9,561,000 | EPS -$0.17 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/29/2013 3:57:06 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Assets $9,561,000 | EPS -$0.72 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/9/2012 2:13:42 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Assets $11,193,000 | EPS -$0.19 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/9/2012 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2012 | Assets $11,193,000 | EPS -$0.19 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/10/2012 1:46:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Assets $13,322,000 | EPS -$0.19 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/10/2012 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2012 | Assets $13,322,000 | EPS -$0.19 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/11/2012 1:27:34 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Assets $15,538,000 | EPS -$0.17 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 5/11/2012 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2012 | Assets $15,538,000 | EPS -$0.17 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 4/20/2012 7:14:09 AM | View | Proxy | SEC | Y 2011 | ||||||
| GALECTIN THERAPEUTICS INC (GALT) | 3/30/2012 2:36:05 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Assets $6,612,000 | EPS -$1.06 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 3/30/2012 12:00:00 AM | View | Financials | Earnings | SEC | Y 2011 | Assets $6,612,000 | EPS -$0.29 | Export Earnings Model | ||
| GALECTIN THERAPEUTICS INC (GALT) | 11/10/2011 4:00:42 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Assets $8,103,000 | EPS -$0.19 | ||
| GALECTIN THERAPEUTICS INC (GALT) | 8/12/2011 8:15:42 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Assets $8,160,000 | EPS -$0.34 | ||
| PRO PHARMACEUTICALS INC (GALT) | 4/11/2011 5:45:24 PM | View | Proxy | SEC | Y 2010 | ||||||
| PRO PHARMACEUTICALS INC (GALT) | 2/10/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Assets $6,300,000 | EPS -$0.80 | Export Earnings Model | ||
| PRO PHARMACEUTICALS INC (GALT) | 1/6/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Assets $6,300,000 | EPS -$0.80 | Export Earnings Model | ||
| PRO PHARMACEUTICALS INC (GALT) | 3/26/2010 10:05:51 AM | View | Proxy | SEC | Y 2009 | ||||||
| PRO PHARMACEUTICALS INC (GALT) | 8/14/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model | ||||
| PRO PHARMACEUTICALS INC (GALT) | 5/15/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| PRO PHARMACEUTICALS INC (GALT) | 4/21/2009 8:15:44 AM | View | Proxy | SEC | Y 2008 | ||||||
| PRO PHARMACEUTICALS INC (GALT) | 3/30/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |